Skip to main content

Table 1 Baseline characteristics (n = 21)

From: A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma

 

No. of patients

Percentage

Age, years

 Median (range)

53 (24–76)

Gender

 Male

15

71

 Female

6

29

ECOG performance status

 0

4

19

 1

16

76

 2

1

5

Primary site

 Scalp

6

29

 Non-scalp

  Visceral organs (e.g., liver)

7

33

  Heart

5

24

  Skin

2

10

  Breast

1

5

FNCLCC grade

 1

1

5

 2

7

33

 3

9

43

 Unknown

4

19

Initial stage at diagnosis

 III

11

52

 IV

10

48

Laboratory (mean, SD)

 Hemoglobin, g/dL

12.6 (2.0)

 Corrected calcium, mg/dL

9.3 (0.7)

 Lactate dehydrogenase, U/L

372 (243)

Number of metastatic site(s)

 Median (range)

2 (1–4)

Sites of metastases

 Lung

12

57

 Lymph nodes

9

43

 Bone

5

24

 Spleen

3

14

 Liver

1

5

  1. ECOG Eastern Cooperative Oncology Group, FNCLCC Fédération Nationale des Centres de Lutte Contre le Cancer